Blue light photodynamic therapy with 5-aminolevulinic acid in refractory mycosis fungoides: A prospective, open-label study

J Am Acad Dermatol. 2021 Oct;85(4):969-971. doi: 10.1016/j.jaad.2021.01.053. Epub 2021 Jan 23.

Affiliations

¹ Department of Dermatology, Mayo Clinic Arizona, Phoenix, Arizona.
² Department of Health Sciences Research, Mayo Clinic Arizona, Phoenix, Arizona.
³ Department of Radiation Oncology, Mayo Clinic Arizona, Phoenix, Arizona.
⁴ Division Hematology-Oncology, Department of Medicine, Mayo Clinic Arizona, Phoenix, Arizona.
⁵ Department of Dermatology, Mayo Clinic Arizona, Phoenix, Arizona. Electronic address: [email protected].

PMID: 33493572
DOI: 10.1016/j.jaad.2021.01.053

No abstract available

Publication types

Letter

MeSH terms

Aminolevulinic Acid / therapeutic use
Humans
Mycosis Fungoides* / drug therapy
Photochemotherapy*
Photosensitizing Agents / therapeutic use
Prospective Studies
Skin Neoplasms* / drug therapy

Substances

Photosensitizing Agents
Aminolevulinic Acid